Jacqueline Pérez-Pazos

Jacqueline Pérez-Pazos

Auto-generated profile, based on publicly available information

Jacqueline Pérez-Pazos

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Journal of Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
MEMiguel Estravís
Miguel Estravís
AGAsuncion Garcia-Sanchez
Asuncion Garcia-Sanchez
MMMaria J. Martin
Maria J. Martin
JPJacqueline Pérez-Pazos
Jacqueline Pérez-Pazos
MIMaria Isidoro-Garcia
Maria Isidoro-Garcia
CSCatalina Sanz-Lozano
Catalina Sanz-Lozano
Allergic asthma is the most common type of asthma. It is characterized by TH2 cell–driven inflammation in which interleukin-13 (IL-13) plays a pivotal role. Cytoplasmic RNAs (Y-RNAs), a variety of non-coding RNAs that are dysregulated in many cancer types, are also differentially expressed in patients with allergic asthma. Their function in the development of the disease is still unknown. We investigated the potential role of RNY3 RNA (hY3) in the TH2 cell inflammatory response using the Jurkat cell line as a model. hY3 expression levels were modulated to mimic the upregulation effect in allergic disease. We evaluated the effect of hY3 over cell stimulation and the expression of the TH2 cytokine IL13. Total RNA was isolated and retrotranscribed, and RNA levels were assessed by qPCR. In Jurkat cells, hY3 levels increased upon stimulation with phorbol 12-myristate 13-acetate (PMA) and ionomycin. When transfecting with high levels of hY3 mimic molecules, cell proliferation rate decreased while IL13 mRNA levels increased upon stimulation compared to stimulated control cells. Our results show the effect of increased hY3 levels on cell proliferation and the levels of IL13 mRNA in Jurkat cells. Also, we showed that hY3 could act over other cells via exosomes. This study opens up new ways to study the potential regulatory function of hY3 over IL-13 production and its implications for asthma development.

28 August 2023 in Allergy
Verified
Journal Article
Open access
MEMiguel Estravís
Miguel Estravís
JPJacqueline Pérez‐Pazos
Jacqueline Pérez‐Pazos
EMEmma Moreno‐Jimenez
Emma Moreno‐Jimenez
JTJuan Carlos Triviño
Juan Carlos Triviño
AGAsuncion Garcia-Sanchez
Asuncion Garcia-Sanchez
IDIgnacio Dávila
Ignacio Dávila

11 April 2024 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
JPJacqueline Pérez-Pazos
Jacqueline Pérez-Pazos
AGAsuncion Garcia-Sanchez
Asuncion Garcia-Sanchez
MEMiguel Estravís
Miguel Estravís
EMEmma Moreno-Jimenez
Emma Moreno-Jimenez
NMNatalia Morgado
Natalia Morgado
IDIgnacio Dávila
Ignacio Dávila
Introduction: Type 2 (T2) asthma is often associated with chronic rhinosinusitis with nasal polyposis (CRSwNP). Additionally, nonsteroidal anti-inflammatory drug (NSAID) intolerance leads to NSAID-exacerbated respiratory disease (N-ERD). Previous transcriptomic data in non-CRSwNP T2 asthma patients showed differentially expressed genes. We focused onALOX15,CLC,CYSLTR2,HRH4andSMPD3to investigate their role in T2 asthma.Methods: The study included 100 healthy controls and 103 T2 asthma patients, divided into patients with asthma (n=54), patients with asthma and CRSwNP (n=29) and patients with N-ERD (n=20). Quantitative PCR analysis was performed on blood-derived RNA samples first to validate the five differentially expressed genes. The data were further analysed to find potential associations and biomarkers.Results: Patients, regardless of stratification, exhibited significantly higher gene expression than healthy controls. The patterns of association revealed thatALOX15was exclusively present in the non-comorbidity group,SMPD3andCLCin the comorbidity groups, andHRH4in all patient groups.ALOX15,CYSLTR2andSMPD3expression showed potential as biomarkers to confirm the diagnosis of T2 asthma using peripheral blood eosinophils as the initial criterion. Peripheral blood eosinophils combined with gene expression, especiallySMPD3, may improve the diagnosis.CLCandCYSLTR2expression play a specific role in discriminating N-ERD.Discussion: We validated the transcriptomic data of five differentially expressed genes in T2 asthma. Different patterns of association were identified in patient stratification, suggesting that different molecular mechanisms underlie the spectrum of T2 asthma. Potential biomarkers were also found and used to design an algorithm with practical diagnostic utility for T2 asthma, including risk stratification for N-ERD.